Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc, Sumitomo Dainippon Pharma Co LtdfiledCriticalIntercept Pharmaceuticals Inc
Priority claimed from PCT/US2016/029369external-prioritypatent/WO2016176208A1/en
Publication of MA41529A1publicationCriticalpatent/MA41529A1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
La présente invention concerne des formulations d'acide obéticholique à stabilité, dissolution, et/ou solubilité améliorée(s), des procédés de préparation de celles-ci pour utilisation et des procédés de traitement de diverses maladies et états.The present invention provides improved stability, dissolution, and / or solubility acidic obturate acid formulations, methods for their preparation for use and methods of treating various diseases and conditions.
MA41529A2015-04-272016-04-26
Obeticholic acid compositions and methods of use
MA41529A1
(en)